2968 Federal Register / Vol. 89, No. 11 / Wednesday, January 17, 2024 / Notices 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; HHS–NIH–CDC–SBIR PHS 

2024–1 Phase I: Adjuvant Development for 

Vaccines for Infectious and ImmuneMediated Diseases (Topic 128). 

Date: February 8–9, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G22, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Michael M. Opata, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G22, Rockville, MD 

20852, 240–627–3319, michael.opata@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 11, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–00774 Filed 1–16–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Surgery, 

Anesthesiology and Trauma Study Section. 

Date: February 7–8, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Weihua Luo, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5114, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

1170, luow@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Pathophysiological Basis of Mental 

Disorders and Addictions Study Section. 

Date: February 7–8, 2024. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Boris P. Sokolov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217A, 

MSC 7846, Bethesda, MD 20892, 301–408– 

9115, bsokolov@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Imaging Probes and 

Contrast Agents Study Section. 

Date: February 8–9, 2024. 

Time: 7:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree McLean Tysons, 1960 

Chain Bridge Road, McLean, VA 22101. 

Contact Person: Donald Scott Wright, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

8363, wrightds@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group; Macromolecular Structure 

and Function C Study Section. 

Date: February 8–9, 2024. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Bethesdan Hotel, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Guillermo Andres 

Bermejo, Ph.D., Scientific Review Officer, 

The Center for Scientific Review, The 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, (301) 827–5742, 

bermejog@mail.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group; Mechanisms of Cancer Therapeutics 

B Study Section. 

Date: February 8–9, 2024. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6705 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Maria Dolores Arjona 

Mayor, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 806D, Bethesda, MD 20892, (301) 827– 

8578, dolores.arjonamayor@nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Sensory-Motor 

Neuroscience Study Section. 

Date: February 8–9, 2024. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency, Bethesda One, 

Bethesda Metro Center, Bethesda, MD 20814. 

Contact Person: Alena Valeryevna 

Savonenko, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 1009J, Bethesda, MD 20892, (301) 594– 

3444, savonenkoa2@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; Basic 

Mechanisms of Diabetes and Metabolism 

Study Section. 

Date: February 8–9, 2024. 

Time: 8:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites—Old Town 

Alexandri,a Hilton Alexandria Old Town, VA 

22314. 

Contact Person: Baskaran Thyagarajan, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 800B, 

Bethesda, MD 20892, (301) 594–0331, 

BASKI.THYAGARAJAN@NIH.GOV, 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Language and Communication Study 

Section. 

Date: February 8–9, 2024. 

Time: 8:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Plaza Hotel, 10 Thomas 

Circle NW, Washington, DC 20005. 

Contact Person: Rochelle Francine 

Hentges, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 1000C, Bethesda, MD 20892, (301) 

402–8720, hentgesrf@mail.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Kidney Endocrine and Digestive Disorders 

Study Section. 

Date: February 8–9, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Steven M. Frenk, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3141, 

Bethesda, MD 20892, (301) 480–8665, 

frenksm@mail.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group; 

Atherosclerosis and Vascular Inflammation 

Study Section. 

Date: February 8–9, 2024. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 11 / Wednesday, January 17, 2024 / Notices 2969 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Natalia Komissarova, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5207, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1206, komissar@mail.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Clinical Informatics and Digital Health Study 

Section. 

Date: February 8–9, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Paul Hewett, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room, 

Bethesda, MD 20892, (240) 672–8946, 

hewettmarxpn@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group; 

Drug and Biologic Disposition and Toxicity 

Study Section. 

Date: February 8–9, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Hilton Garden Inn, Washington 

DC/Georgetown, 2201 M Street NW, 

Washington, DC 20037. 

Contact Person: Stacey Nicole Williams, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 867–5309, stacey.williams@

nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Interdisciplinary Clinical Care in Specialty 

Care Settings Study Section. 

Date: February 8–9, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Hybrid Meeting). 

Contact Person: Abu Saleh Mohammad 

Abdullah, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 827–4043, 

abuabdullah.abdullah@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 11, 2024. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–00754 Filed 1–16–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Substance Abuse 

Treatment; Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Treatment 

(CSAT) National Advisory Council 

(NAC) will meet on February 27, 2024, 

9:00 a.m.–4:30 p.m. (EST). 

The meeting is open to the public and 

will include consideration of minutes 

from the SAMHSA CSAT NAC meeting 

of August 29, 2023, a discussion with 

SAMHSA leadership, a discussion on 

housing and homelessness, a discussion 

on the activities of the 

Interdepartmental Substance Use 

Disorders Coordinating Committee, and 

a discussion on the following CSAT 

programs, the Minority Fellowship 

Program, the Center of Excellence, and 

Historically Black Colleges and 

Universities Center of Excellence in 

Behavioral Health. This meeting will 

also cover updates on CSAT activities 

from the Office of the Director; the 

Division of Pharmacologic Therapies; 

the Division of States and Community 

Systems; the Division of Services 

Improvement; Office of Program 

Analysis and Coordination; Office of 

Performance Analysis and Management. 

The meeting will be held at SAMHSA, 

5600 Fishers Lane, 5N76, Rockville, MD 

20857. Attendance by the public will be 

limited to space available and will be 

limited to the open sessions of the 

meeting. Interested persons may present 

data, information, or views, orally or in 

writing, on issues pending before the 

Council. Presentations from the public 

will be scheduled at the conclusion of 

the meeting. Individuals interested in 

making oral presentations must notify 

the contact person, Tracy Goss, CSAT 

NAC Designated Federal Officer (DFO) 

on or before February 16, 2024. Up two 

minutes will be allotted for each 

approved public comment as time 

permits. Written comments received in 

advance of the meeting will be 

considered for inclusion in the official 

record. 

The open meeting session may also be 

accessed virtually. Please register online at https://snacregister.samhsa.gov, 

to attend on either on site or virtually, 

submit written or brief oral comments, 

or request special accommodations for 

persons with disabilities. To 

communicate with the CSAT NAC DFO 

please see the contract information 

below. 

Meeting information and a roster of 

Council members may be obtained by 

accessing the SAMHSA Committee 

website at https://www.samhsa.gov/ 

about-us/advisory-councils/csatnational-advisory-council, or by 

contacting the DFO. 

Council Name: SAMHSA’s Center for 

Substance Abuse Treatment National 

Advisory Council. 

Date/Time/Type: August 29, 2023, 

9:00 a.m.–4:30 p.m. EST, OPEN. 

Place: SAMHSA, 5600 Fishers Lane, 

Rockville, Maryland 20857. 

Contact: Tracy Goss, Designated 

Federal Officer, CSAT National 

Advisory Council, 5600 Fishers Lane, 

Rockville, Maryland 20857 (mail), 

Telephone: (240) 276–0759, Email: 

tracy.goss@samhsa.hhs.gov. 

Dated: January 10, 2024. 

Carlos Castillo, 

Committee Management Officer, SAMHSA. 

[FR Doc. 2024–00746 Filed 1–16–24; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Meeting of the Substance Abuse and 

Mental Health Services Administration, 

Center for Mental Health Services 

National Advisory Council 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: Pursuant to Public Law 92– 

463, notice is hereby given of the 

meeting on February 27, 2024, of the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA), 

Center for Mental Health Services 

National Advisory Council (CMHS 

NAC). 

The meeting is open to the public and 

will include consideration of the 

meeting minutes from the August 29, 

2023, SAMHSA, CMHS NAC meeting; 

updates from the CMHS Director; 

remarks from SAMHSA’s Assistant 

Secretary; updates on Statewide 

Consumer Network Grants; updates on 

Subcommittee Tasks; Legislative 

updates; and Tribal updates. Agenda 

with call-in information will be posted 

on the SAMHSA website prior to the 

meeting at: https://www.samhsa.gov/ 

about-us/advisory-councils/meetings. 

The meeting will be held at SAMHSA, 

5600 Fishers Lane, 5W11, Rockville, MD 

20857. Attendance by the public will be 


lotter on DSK11XQN23PROD with NOTICES1